Select for export Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1287196 PubMed 38025484 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-11-12 Tor-Morten Kvam, Malin V. Uthaug, Kristoffer Andreas Aamodt Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan H. Stewart OpenAlex Published psilocybin AddictionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Manic episode following psilocybin use in a man with bipolar II disorder: a case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1221131 PubMed 37810598 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-21 Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur OpenAlex Published psilocybin DepressionAddictionOCD Case Report More
Select for export Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1159843 PubMed 37799400 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-19 Taylor Black OpenAlex Published psilocybin AddictionWellbeingSafety Other More
Select for export Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1199642 PubMed 37795509 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-18 Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe OpenAlex Published psilocybin DepressionAnxietyChronic Pain Observational Study More
Select for export Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1215972 PubMed 37795513 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-17 Keith G. Heinzerling, Karina Sergi, Micah Linton, Rhianna Rich, Brittany Youssef, Inez Bentancourt OpenAlex Published psilocybin AnxietyAddictionChronic Pain Randomized Controlled Trial More
Select for export Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1169692 PubMed 37692301 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-08-23 Grant Jones, Maha Al-Suwaidi, Franchesca Castro-Ramirez, Taylor C. McGuire, Patrick Mair, Matthew K. Nock OpenAlex Published psilocybin Observational StudySafetyToxicity Observational Study More
Select for export Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1224551 PubMed 37599880 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-08-03 Kevin F. Boehnke, Kasey Cox, Cody Weston, Moss Herberholz, Nicolas Glynos, Nicholas Kolbman OpenAlex Published psilocybin SafetyAdverse EventsDrug Interactions Other More
Select for export Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1136990 PubMed 37457761 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-06-28 Winston De La Haye, G Walcott, Jordan Eaton, Jhoelle Beckford, Janelle D. Greene OpenAlex Published psilocybin Mechanism of ActionPersonality ChangeMystical Experience Clinical Trial More
Select for export Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1197890 PubMed 37435405 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-06-25 Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza OpenAlex Published psilocybinpsilocin DepressionAddictionNeuroplasticity Review Article More
Select for export Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1178529 PubMed 37181888 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-04-24 Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico OpenAlex Published psilocybin OCDChronic PainBrain Imaging Randomized Controlled Trial More
Select for export Classic psychedelics do not affect T cell and monocyte immune responses Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1042440 PubMed 36741125 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-19 Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann OpenAlex Published psilocin End-of-Life DistressPharmacologyReceptor Pharmacology In Vitro Study More
Select for export The association between naturalistic use of psychedelics and co-occurring substance use disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1066369 PubMed 36704738 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-09 Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross OpenAlex Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.883869 PubMed 35873251 Copy citation Copy BibTeX Frontiers in Psychiatry 2022-07-06 Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL. Europe PMC Published psilocybinpsilocin AnxietyMechanism of ActionPersonality Change Observational Study More
Select for export Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.891512 PubMed 35664477 Copy citation Copy BibTeX Frontiers in Psychiatry 2022-05-17 Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. Europe PMC Published psilocybinpsilocin Receptor PharmacologyAnimal Study Animal Study More
Select for export Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.906487 PubMed 35633783 Copy citation Copy BibTeX Frontiers in Psychiatry 2022-05-10 Stephan Schleim OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.727572 PubMed 34950063 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-12-06 Whitfield HJ. Europe PMC Published psilocybin DepressionPTSDMechanism of Action Review Article More
Select for export Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.735523 PubMed 34744825 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-10-19 Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC Europe PMC Published psilocybin Eating DisordersEnd-of-Life DistressNeuroplasticity Clinical Trial More
Select for export New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.727050 PubMed 34566724 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-09-09 Tehseen Noorani, Jonny Martell OpenAlex Published psilocybin DepressionReceptor PharmacologyWellbeing Clinical Trial More
Select for export Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyt.2021.716593 PubMed 34552518 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-09-05 Argento E, Christie D, Mackay L, Callon C, Walsh Z. Europe PMC Published psilocybin General Other More
Select for export Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2021.688439 PubMed 34421675 Copy citation Copy BibTeX Frontiers in Psychiatry 2021-08-05 Mendes Rocha J, Rossi GN, Osório FL, Bouso Saiz JC, Silveira GO, Yonamine M Europe PMC Published psilocybin Personality ChangeHealthy Volunteers Clinical Trial More
